One telephone call triggered a new device that aims to give surgeons more precise diagnostic information about what to cut and what to preserve during cancer surgery.
Livia Schiavinato Eberlin, Ph.D., assistant professor of chemistry at The University of Texas (UT) at Austin, made that phone call, and James Suliburk, M.D., associate professor and head of endocrine surgery at Baylor College of Medicine, answered it.
“She wanted to test a mass spectrometer to see if it would rule in or rule out cancer,” Suliburk said. “I responded with ‘Yes!’”
Mass spectrometry is a fairly new application within clinical settings, Suliburk said. A mass spectrometer measures characteristics of individual molecules. Eberlin wanted to test the MasSpec Pen, a handheld device that can detect cancer by touch—in real time.
A surgeon holds the MasSpec Pen against the patient’s tissue and uses a foot pedal to trigger the automated analysis, waiting a few seconds for a result. The pen releases a drop of water onto the tissue, and small molecules from the tissue migrate into the water.
Then the device drives the water sample into the mass spectrometer, which reads thousands of molecules as a molecular fingerprint. When the MasSpec Pen completes the tissue analysis, the words “Normal” or “Cancer” appear automatically on a computer screen. Surgeons then know which tissue to remove and which tissue to leave in the body.
Significantly, the pen allows surgeons to analyze tissue while it’s still in the body, unlike frozen section analysis, the current method for diagnosing cancer during surgery and determining the boundary between cancerous tissue and healthy tissue.
The frozen section process, which has been around for 100 years, involves the removal of tissue or an organ so it can be studied under a microscope. Frozen section is often slow and sometimes inaccurate, and each sample can take a pathologist as much as 45 minutes to prepare and interpret, increasing the patient’s risk for infection.
In addition, frozen section analysis is difficult to interpret for some types of cancers. And once the tissue or organ is removed, it can’t be put back, said Suliburk, who often operates on the thyroid.
“We operate to remove a part of or all of the thyroid,” he said. “What we find is that a majority of the patients will not have cancer, but until now, our diagnostics were not to the point, yet, where we could improve that procedure.”
But with the MasSpec Pen, cancerous tissue is accurately identified in about 10 seconds, he said.
The MasSpec Pen was developed by a team of scientists, surgeons and James Suliburk, engineers from UT Austin, Baylor and The University of Texas MD Anderson Cancer Center.
Led by Eberlin, the team has demonstrated that the pen diagnoses cancer in live, tumor-bearing mice during surgery without causing any observable harm to the tissue or stress to the animals.
“We anticipate certain lesions will be 90 to 95 percent probable of a tissue diagnosis, but we want to give a more precise diagnosis,” Suliburk said. “Our goal is to be more than 95 percent accurate.”
The team is now refining the MasSpec Pen so it can read samples placed on microscope slides.
Suliburk expects to start testing the MasSpec Pen during oncologic surgeries this spring. The team hopes the U.S. Food and Drug Administration will approve the pen as a medical diagnostic.
“Dr. Eberlin and I both feel strongly that it will improve the care of the patient and revolutionize how we perform surgery,” Suliburk said. “Any time you can perform a more precise, safer surgery, it’s a win for the patients and results in better outcomes.”
“I'm a huge believer in always biopsying the first site of metastatic disease, especially to recheck the ER/PR and HER2 status,” says our @JenniferLitton of how data shows #breastcancer can change with metastasis. #bcsm #endcancer https://t.co/DzL4k31aQn
We have gone purple this week for Domestic Violence Awareness month. Learn how you can help: https://t.co/CxrGw0N0S9 #domesticviolenceawareness #domesticviolenceawarenessmonth https://t.co/2S19KMnHOh
Meet the people behind the papers – George Britton and Aryeh Warmflash: https://t.co/9DTjXt8Iow via @Co_Biologists https://t.co/4boMPVOMg0
Weston spent his summers training for the upcoming football & basketball seasons. When his mom noticed he was losing steam, they decided it was time for a trip to the doctor's office. They never expected it to be cancer. Read Weston's story: https://t.co/4CEbwUWpi5 #ThisIsCancer https://t.co/w6Nun5rKkI
RT @WebsEdge_Health: ASHG TV sat down with Brendan Lee, Professor & Chairman, Dept. of Molecular & Human #Genetics @bcmhouston to learn mor…
“One of the important questions we want to answer is ‘Why don’t these work better?’”@AnnKloppMD explains how our HPV-Related Cancers Moon Shot is working to overcome barriers using #immunotherapy: https://t.co/kL6uLPuGFj @CancerFrontline #CancerMoonshot #endcancer
Join us for the "Grill Your Ace Off" event this Saturday, October 19 with Cypress @AceHardware! Proceeds benefit @CMNHospitals: https://t.co/UeNuaDzp9h
A new technique developed by Rice bioscientists has allowed them to make the most comprehensive analysis yet of signaling pathways that drive patterning of human ectoderm.Read more: https://t.co/fmCDuInplI https://t.co/6iBO8MfaCI
University of Houston@UHouston
RT @GetInvolvedUH: Join us for InfraRED: Spooktacular TONIGHT from 7:00-10:00PM in the Student Centers Houston Room. This year’s activities…
University of Houston@UHouston
RT @UHoustonLib: .@UH_Arch_Art_Lib is pleased to host an opening reception for student artist Morgan Stahl on November 8https://t.co/Eq2V…
Veterans getting better care through partnerships, says VA secretary https://t.co/j29GiiYZSQ via #VAntagePoint
Mark your calendars for @BCMCancerCenter’s Lights Out, Cancer event happening Feb. 8. To learn more about this event or how you could participate even if you can't attend, please visit: https://t.co/DcJyiczUvu #BCMLightsOutCancer #BCMLOC https://t.co/uwVfAQxgcO
Finding your way around one of the largest cancer centers in the world can be daunting. Here’s how our patient escorts can help: https://t.co/e1w2DxY0VX #endcancer
"The circulatory system’s response to panic...a pounding feeling in the head or chest and/or prompt feelings of lightheadedness or dizziness, according to the Texas Heart Institute. https://t.co/yfBHBgwHuC @Texas_Heart
RT @RiceArch: This week's episode of the Rice Architecture podcast Tête-à-Tête features a conversation with student Ethan Chan about the Ri…